ODC Therapy Report issue

For profit Phase 2
Founded: Dallas TX United States (2004)
Status: Left NME R&D (2005)

Organization Overview

First Clinical Trial
2005
NCT00125749
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now